Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Florida
Low Risk - Total of 70 Gy/CGE over 28 treatments
Intermediate Risk - Total of 72.5 Gy/CGE over 29 treatments
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Prostate cancer.
Gleason score 2-7.
PSA ≤ 20 ng/ml.
You may not be if
Previous prostate cancer surgery or pelvic radiation.
Prior or current chemotherapy for prostate cancer.
Active inflammatory bowel disease (Crohn's disease, diverticulitis or ulcerative colitis) affecting the rectum.
History of proximal urethral stricture requiring dilatation.
History of hip replacement.
Diabetes requiring medication.
Prior intrapelvic surgery.
Current and continuing anticoagulation with Warfarin sodium (Coumadin), Clopidogrel bisulfate (Plavix), enoxaparin sodium (Lovenox), or aspirin/er dipyridamole (Aggrenox).
On Flomax (Tamsulosin), Hytrin (Terazosin) or Cardura (Doxazosin), Uroxatral (alfuzosin HCl).
Taking Saw Palmetto or methotrexate and unable or unwilling to discontinue its use during radiation.
